Judit Demeter

5.0k total citations
117 papers, 1.6k citations indexed

About

Judit Demeter is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Judit Demeter has authored 117 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Genetics, 43 papers in Pathology and Forensic Medicine and 36 papers in Hematology. Recurrent topics in Judit Demeter's work include Chronic Lymphocytic Leukemia Research (44 papers), Lymphoma Diagnosis and Treatment (38 papers) and Immunodeficiency and Autoimmune Disorders (14 papers). Judit Demeter is often cited by papers focused on Chronic Lymphocytic Leukemia Research (44 papers), Lymphoma Diagnosis and Treatment (38 papers) and Immunodeficiency and Autoimmune Disorders (14 papers). Judit Demeter collaborates with scholars based in Hungary, Germany and United States. Judit Demeter's co-authors include A M Lawrence, E Paloyan, Gerald Messer, Andrés J.M. Ferreri, Maurilio Ponzoni, Claudio Doglioni, Steven A. De Jong, Carlo de Conciliis, Antonia Anna Lettini and Antonio Giordano Resti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Judit Demeter

103 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judit Demeter Hungary 18 562 553 426 413 301 117 1.6k
Anne Lennard United Kingdom 20 562 1.0× 831 1.5× 414 1.0× 561 1.4× 218 0.7× 51 1.6k
Norifumi Tsukamoto Japan 25 561 1.0× 706 1.3× 826 1.9× 433 1.0× 381 1.3× 139 2.1k
Shin Fujisawa Japan 27 561 1.0× 410 0.7× 1.1k 2.5× 572 1.4× 380 1.3× 182 2.2k
AA Morley Australia 16 462 0.8× 743 1.3× 389 0.9× 451 1.1× 228 0.8× 23 1.5k
Maria K. Angelopoulou Greece 23 693 1.2× 869 1.6× 445 1.0× 702 1.7× 470 1.6× 134 1.9k
Kaaren K. Reichard United States 22 611 1.1× 576 1.0× 515 1.2× 413 1.0× 237 0.8× 116 1.7k
Piero Galieni Italy 26 564 1.0× 700 1.3× 739 1.7× 706 1.7× 487 1.6× 89 1.7k
Marina P. Siakantaris Greece 22 525 0.9× 766 1.4× 265 0.6× 430 1.0× 258 0.9× 74 1.4k
Wing Y. Au China 24 502 0.9× 1.1k 1.9× 383 0.9× 732 1.8× 324 1.1× 75 1.9k
Surender Juneja Australia 20 538 1.0× 541 1.0× 489 1.1× 375 0.9× 288 1.0× 85 1.3k

Countries citing papers authored by Judit Demeter

Since Specialization
Citations

This map shows the geographic impact of Judit Demeter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judit Demeter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judit Demeter more than expected).

Fields of papers citing papers by Judit Demeter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judit Demeter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judit Demeter. The network helps show where Judit Demeter may publish in the future.

Co-authorship network of co-authors of Judit Demeter

This figure shows the co-authorship network connecting the top 25 collaborators of Judit Demeter. A scholar is included among the top collaborators of Judit Demeter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judit Demeter. Judit Demeter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Batár, Péter, Hussain Alizadeh, György Rokszin, Zsolt Abonyi‐Tóth, & Judit Demeter. (2024). Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary. Pathology & Oncology Research. 30. 1611497–1611497. 1 indexed citations
2.
Lakatos, Péter L., Ildikó Beke Debreceni, Balázs Szili, et al.. (2024). Case report: Comprehensive clinical, pathological and genetic investigations to decipher the background of cyclic thrombocytopenia. Pathology & Oncology Research. 30. 1611914–1611914.
3.
4.
Varga, Gergely, Zsolt Nagy, Judit Demeter, et al.. (2019). Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program. Pathology & Oncology Research. 25(4). 1615–1620. 17 indexed citations
5.
Tímár, Botond, Tibor Krenács, Hussain Alizadeh, et al.. (2018). Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms. Pathology. 51(3). 301–307. 5 indexed citations
6.
Uzonyi, Barbara, Szilvia Lukácsi, Katalin Török, et al.. (2017). Functional studies of chronic lymphocytic leukemia B cells expressing β 2 -integrin type complement receptors CR3 and CR4. Immunology Letters. 189. 73–81. 9 indexed citations
7.
Rosta, András, Hajna Losonczy, Miklós Egyed, et al.. (2017). Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study). Pathology & Oncology Research. 24(2). 199–205. 4 indexed citations
8.
Sinkovits, György, Péter Farkas, Dorottya Csuka, et al.. (2014). Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura. Thrombosis Research. 133(4). 616–621. 15 indexed citations
9.
Demeter, Judit, et al.. (2013). The stiff-person syndrome: a brief review and report of two cases. Orvosi Hetilap. 154(50). 1984–1990. 2 indexed citations
10.
Takács, István, Ilona Benkő, Norbert Wikonkál, et al.. (2012). Hazai konszenzus a D-vitamin szerepéről a betegségek megelőzésében és kezelésében. Repository of the Academy's Library (Library of the Hungarian Academy of Sciences). 8 indexed citations
11.
Tamas, Laszlo B., Gábor Répássy, Péter M. Szabó, et al.. (2011). Spontaneous Remission in Localized Diffuse Large B-cell Lymphoma. Pathology & Oncology Research. 17(3). 779–784. 15 indexed citations
12.
Sebestyén, Anna, et al.. (2007). Activity of the Notch‐signalling Pathway in Circulating Human Chronic Lymphocytic Leukaemia Cells. Scandinavian Journal of Immunology. 65(3). 271–275. 10 indexed citations
13.
Dong, Fan, Sufeng Li, Núria Pujol‐Moix, et al.. (2005). Genotype–phenotype correlation in MYH9‐related thrombocytopenia. British Journal of Haematology. 130(4). 620–627. 62 indexed citations
14.
Demeter, Judit, et al.. (2001). Familial occurrence of the May-Hegglin anomaly: is the accompanying renal failure part of a new subentity?. Annals of Hematology. 80(6). 368–371. 2 indexed citations
15.
Pajor, Attila, László Nemes, & Judit Demeter. (1999). May-Hegglin anomaly and pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 85(2). 229–231. 4 indexed citations
16.
Demeter, Judit, Gerald Messer, John Mee, et al.. (1996). Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies.. PubMed. 2(4). 239–42. 27 indexed citations
17.
Demeter, Judit, et al.. (1994). Bone densitometry and histomorphometry in patients with hairy cell leukemia.. PubMed. 14 Suppl 1. 73–7. 5 indexed citations
18.
Pálóczi, Katalin, Judit Demeter, Éva Pócsik, et al.. (1990). Differentiation and activation antigens associated with hairy cell leukemia.. PubMed. 4(10). 694–694. 1 indexed citations
19.
Pálóczi, Katalin, et al.. (1990). Detection of Activation Antigens on Chronic Lymphocytic Leukaemia Cells. Leukemia & lymphoma. 3(1). 31–36. 3 indexed citations
20.
Demeter, Judit, et al.. (1984). [Treatment of hairy cell leukemia by irradiation of the spleen].. PubMed. 109(15). 597–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Lennard Breakdown of academic impact, for papers by Norifumi Tsukamoto Breakdown of academic impact, for papers by Shin Fujisawa Breakdown of academic impact, for papers by AA Morley Breakdown of academic impact, for papers by Maria K. Angelopoulou Breakdown of academic impact, for papers by Kaaren K. Reichard Breakdown of academic impact, for papers by Piero Galieni Breakdown of academic impact, for papers by Marina P. Siakantaris Breakdown of academic impact, for papers by Wing Y. Au Breakdown of academic impact, for papers by Surender Juneja
Rankless by CCL
2026